[Effect of 3,4-dihydroxyphenylalanine (levodopa) in hepatic coma].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D004569:Electroencephalography; D005260:Female; D006501:Hepatic Encephalopathy / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D009461:Neurologic Manifestations
D004295:Dihydroxyphenylalanine
Accion de 3-4-dihidroxifenilalanina levodopa en el coma hepatico.